PG Procter & Gamble Co

Procter & Gamble is the world's largest consumer goods company, producing household and personal care products under brands like Tide, Pampers, Gillette, and Crest. Sector: Consumer Staples.

Procter & Gamble Co (PG) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On a capital return basis, ROIC is 18.36%, WACC is 5.78%, and the economic spread is 12.58%. On balance, ROIC clears WACC by a meaningful margin, suggesting the company is creating rather than consuming intrinsic value. Supporting metrics show ROE at 31.50% and ROA at 12.03%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

On valuation, the company registers trailing P/E of 21.20, forward P/E of 19.81, PEG of 3.95. The minimal trailing-to-forward compression implies limited earnings growth expectations are embedded in current prices. The PEG ratio is elevated relative to historical norms, implying the market is paying a meaningful premium for the earnings trajectory embedded in analyst estimates. A current ratio of 0.72 signals that short-term coverage is tighter than typical across the company. Taken together, the multiple and liquidity picture suggests a company that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Stripping to unit economics, gross margin sits at 50.94%, operating margin at 24.59%, and free cash flow margin at 17.42%. Gross margins are healthy, suggesting solid pricing power across the company. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, the company demonstrate good cash generation relative to the revenue base. Read in combination, these margins suggest a business model that protects profitability across multiple cost layers.

Revenue trends and analyst expectations together suggest: TTM revenue growth of 1.49% indicating muted but still positive top-line momentum across the company, while the estimated 12-month price change of 17.95%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 7.0%, projected EPS growth is present and positive — not a standout catalyst, but a stabilizing element in the overall forward picture. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the company can sustain the trajectory that is already being priced. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.